Recommendation ID
NG188/2
Question

What is the prevalence and incidence of post-COVID-19 syndrome in patients who have received single, double, or boosted doses of the approved vaccinations in the UK?

Does this vary across different population groups (for example in black, Asian and minority ethnic group communities)?

Any explanatory notes
(if applicable)

Source guidance details

Comes from guidance
COVID-19 rapid guideline: managing the long-term effects of COVID-19
Number
NG188
Date issued
December 2020

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 12/11/2021